{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:25:04Z","timestamp":1791563104501,"version":"4.3.4"},"reference-count":39,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective: We assessed in a retrospective unicenter study the impact of treatment with GnRH analogs (GnRHa) on adult height (AH), body mass index (BMI), bone mineral density (BMD), and reproductive function in girls with idiopathic central precocious puberty (ICPP).<\/jats:p>\n                  <jats:p>Patients: Eighty-seven ICPP patients were treated with GnRHa for 4.2 \u00b1 1.6 yr (range 3\u20137.9) and observed for 9.9 \u00b1 2.0 yr (range 4\u201310.6 yr) after discontinuation of treatment; to estimate the efficacy better, 32 comparable ICPP untreated girls were analyzed.<\/jats:p>\n                  <jats:p>Results: AH was 159.8 \u00b1 5.3 cm, significantly higher than pretreatment predicted AH (PAH) either for accelerated or for average tables of Bayley and Pinneau. The gain in centimeters between pretreatment PAH and AH was 5.1 \u00b1 4.5 and 9.5 \u00b1 4.6 cm, respectively. Hormonal values and ovarian and uterine dimensions, reduced during treatment, increased to normal after 1 yr without therapy. Age of menarche was 13.6 \u00b1 1.1 yr with an interval of 0.9 \u00b1 0.4 yr after therapy. Menstrual pattern was normal. Six girls became pregnant and delivered normal offspring. BMI sd score for chronological age increased, but not significantly, before, during, and after therapy. BMD at discontinuation of treatment was significantly lower and increased to control values after gonadal activity resumption.<\/jats:p>\n                  <jats:p>Conclusions: GnRHa treatment in ICPP is safe for the reproductive system, BMD, and BMI and helpful in reaching AH close to target height; however, the variability of individual responses suggests that one choose more parameters than increment in height, especially in girls with pubertal onset over 8 yr of age.<\/jats:p>","DOI":"10.1210\/jc.2007-1216","type":"journal-article","created":{"date-parts":[[2007,10,16]],"date-time":"2007-10-16T23:19:39Z","timestamp":1192576779000},"page":"190-195","source":"Crossref","is-referenced-by-count":196,"title":["Long-Term Observation of 87 Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogs: Impact on Adult Height, Body Mass Index, Bone Mineral Content, and Reproductive Function"],"prefix":"10.1210","volume":"93","author":[{"given":"Anna Maria","family":"Pasquino","sequence":"first","affiliation":[{"name":"Department of Pediatrics, \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Pucarelli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Accardo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitan","family":"Demiraj","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Segni","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Di Nardo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613253470200_R1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jcem-52-2-370","article-title":"Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty.","volume":"52","author":"Crowley","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1210\/jcem-73-6-1235","article-title":"Adult height in precocious puberty after long-term treatment with deslorelin.","volume":"73","author":"Oerter","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R3","first-page":"331","article-title":"Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty.","volume":"79","author":"Kletter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R4","first-page":"546","article-title":"Long term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years.","volume":"80","author":"Paul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/adc.75.4.292","article-title":"Final height in central precocious puberty after long term treatment with a slow release GnRH agonist.","volume":"75","author":"Oostdijk","year":"1996","journal-title":"Arch Dis Child"},{"key":"2020071613253470200_R6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1530\/eje.0.1410140","article-title":"Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty.","volume":"141","author":"Arrigo","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071613253470200_R7","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jcem.84.6.5647","article-title":"Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment.","volume":"84","author":"Carel","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R8","first-page":"4583","article-title":"Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.","volume":"84","author":"Heger","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2020071613253470200_R9","first-page":"773","article-title":"End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty","volume":"13","author":"Antoniazzi","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071613253470200_R10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1515\/JPEM.2000.13.S1.765","article-title":"Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience.","volume":"13","author":"Mul","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071613253470200_R11","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: the national institutes of health experiences.","volume":"86","author":"Klein","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2265.2002.01488.x","article-title":"Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment.","volume":"56","author":"Adan","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613253470200_R13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2004.02146.x","article-title":"Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.","volume":"61","author":"Paterson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613253470200_R14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/jc.2004-1863","article-title":"Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on central precocious puberty.","volume":"90","author":"Tanaka","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls.","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"2020071613253470200_R16","author":"Greulich","year":"1959"},{"key":"2020071613253470200_R17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","article-title":"Tables for predicting adult height from skeletal age: revised for use with the Greulich and Pyle hand standards.","volume":"40","author":"Bayley","year":"1952","journal-title":"J Pediatr"},{"key":"2020071613253470200_R18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000185432","article-title":"Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue.","volume":"47","author":"Kauli","year":"1997","journal-title":"Horm Res"},{"key":"2020071613253470200_R19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/adc.45.244.755","article-title":"Standards for children\u2019s height at ages 2\u20139 allowing for height of parents.","volume":"45","author":"Tanner","year":"1970","journal-title":"Arch Dis Child"},{"key":"2020071613253470200_R20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03344156","article-title":"Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr).","volume":"29","author":"Cacciari","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"2020071613253470200_R21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S8756-3282(95)00162-X","article-title":"Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology.","volume":"17","author":"Kroger","year":"1995","journal-title":"Bone"},{"issue":"Suppl 1","key":"2020071613253470200_R22","first-page":"695","article-title":"Etiology and age incidence of precocious puberty in girls: a multicentric study","volume":"13","author":"Cisternino","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071613253470200_R23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03347256","article-title":"Puberty onset in Northern Italy: a random sample of 3597 Italian children.","volume":"28","author":"Castellino","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2020071613253470200_R24","first-page":"4480","article-title":"Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.","volume":"84","author":"Palmert","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/eje.1.01975","article-title":"Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height.","volume":"152","author":"Traggiai","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071613253470200_R26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/eje.0.1500533","article-title":"Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty.","volume":"150","author":"Arrigo","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071613253470200_R27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/BF01953983","article-title":"Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty.","volume":"152","author":"Saggese","year":"1993","journal-title":"Eur J Pediatr"},{"key":"2020071613253470200_R28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/09513599509160459","article-title":"Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog.","volume":"9","author":"Verrotti","year":"1995","journal-title":"Gynecol Endocrinol"},{"key":"2020071613253470200_R29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1530\/eje.0.1330412","article-title":"Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment.","volume":"133","author":"Antoniazzi","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"2020071613253470200_R30","first-page":"370","article-title":"Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.","volume":"83","author":"Boot","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s004310050831","article-title":"Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.","volume":"157","author":"Bertelloni","year":"1998","journal-title":"Eur J Pediatr"},{"key":"2020071613253470200_R32","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1210\/jcem.84.6.5791","article-title":"Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.","volume":"84","author":"Antoniazzi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/jcem.87.2.8202","article-title":"Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy.","volume":"87","author":"Van der Sluis","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2020071613253470200_R34","first-page":"795","article-title":"Side effects of GnRH analogue treatment in childhood","volume":"13","author":"Tonini","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071613253470200_R35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1210\/jcem-67-2-368","article-title":"Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.","volume":"67","author":"Manasco","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R36","first-page":"890","article-title":"Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists.","volume":"75","author":"Jay","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jcem.84.1.5409","article-title":"Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.","volume":"84","author":"Feuillan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613253470200_R38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00431-006-0207-z","article-title":"Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.","volume":"166","author":"Arrigo","year":"2007","journal-title":"Eur J Pediatr"},{"key":"2020071613253470200_R39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth.","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/1\/190\/9053619\/jcem0190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/1\/190\/9053619\/jcem0190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T19:47:00Z","timestamp":1594928820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/1\/190\/2598478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1216","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}